MARCOVITCH SHARON HOWARD DR PSYCHBusiness Directories,Company Directories

Company Name: Corporate Name:	MARCOVITCH SHARON & HOWARD DR PSYCH
Company Title:
Company Description:
Keywords to Search:
Company Address:	491 Av Lawrence O,NORTH YORK,ON,Canada
ZIP Code: Postal Code:	M5M
Telephone Number:	4167800909
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	185520
USA SIC Description:	PSYCHOLOGISTS
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
MARCOVITZ LEORA DR
MARCOVITZ LEORA DR FAMILY PRACTITI
MARCOVITCH SHARON & HOWARD DR

Next company profile:
MARCOCCIA TRENCHING & EXCVTN
MARCIANO
MARCIA SCHNOOR INSURANCE AGENC

Company News:

Vasant Narasimhan - Wikipedia
Vasant " Vas " Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis [1][2][3][4] He succeeded Joseph Jimenez who left Novartis in 2018 [5]
Vasant Narasimhan | Novartis
Vasant (Vas) Narasimhan, M D , has been Chief Executive Officer (CEO) of Novartis since February 1, 2018
Why Novartis CEO was willing to pay top dollar for Avidity
Novartis CEO paid top dollar for Avidity to become a 'leader in neuromuscular diseases' By James Waldron Nov 20, 2025 4:37am Novartis mergers and acquisitions Avidity Biosciences Vas Narasimhan
Vas Narasimhan – Reimagining medicine as CEO of Novartis | LinkedIn
We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible around the globe As CEO, I’ve worked to focus our company and unleash the power of
Avidity Played Hardball to Land Favorable Terms in $12B Novartis Deal
At one point in merger negotiations with Novartis, Avidity CEO Sarah Boyce and her team walked, cutting off access to a data room and moving on to a capital raise
Novartis CEOs pay rises 21% as Roches new chief nets $11M
In his sixth year as Novartis’ CEO, Narasimhan saw his base salary climb 2% year over year to 1 82 million Swiss francs The largest increase in his compensation package came from his annual
Novartis CEO Vas Narasimhan named to 2025 TIME100 Health list
Novartis has announced that CEO Vas Narasimhan, M D , has been named to the 2025 TIME100 Health list—recognizing 100 of the most influential people driving the future of global health
Vasant Narasimhan | CEO of Novartis | Leader in Global Healthcare
Vasant Narasimhan is at the forefront of the pharmaceutical industry as CEO of Novartis His innovation makes an impact on global health
Episode 458: Novartis CEO Vas Narasimhan on Drug Development AIs . . .
Joining us today is Vas Narasimhan, CEO of Novartis Since joining the company in 2005, Vas has held key leadership roles including global Head of Development and Chief Medical Officer before taking the helm as the chief executive officer in 2018
Vasant Narasimhan Bio – Novartis CEO - The Official Board
Vasant Narasimhan joined Novartis in 2007 Vasant served as Global Head, Development, Vaccines and Diagnostics and Global Head of Drug Development and Chief Medical Officer for Novartis